EyreDWFutschikMTunkelSWeiJCole-HamiltonJSaquibR, et al.
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study. Lancet Infect Dis2023;
23: 922–932.
CrozierARajanSBuchanIMcKeeM.Put to the test: use of rapid testing technologies for covid-19. BMJ (Clinical research ed)2021;
372: n208. 2021/02/05. DOI: 10.1136/bmj.n208.
PetersenICrozierABuchanIMinaMJBartlettJW.Recalibrating SARS-CoV-2 antigen rapid lateral flow test relative sensitivity from validation studies to absolute sensitivity for indicating individuals shedding transmissible virus. Clin Epidemiol2021;
13: 935–940.
17.
FutschikMEJohnsonSTurekEChapmanDCarrSThorlu-BanguraZ, et al.
Rapid antigen testing for SARS-CoV-2 by lateral flow assay: a field evaluation of self- and professional testing at UK community testing sites. J Clin Virol2024;
171: 105654.
18.
LeeLYWRozmanowskiSPangMCharlettAAndersonCHughesGJ, et al.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity by viral load, S gene variants and demographic factors, and the utility of lateral flow devices to prevent transmission. Clin Infect Dis2022;
74: 407–415.
19.
KirbyJERiedelSDuttaSArnaoutRChengADitelbergS, et al.
Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort. Clin Microbiol Inf2023;
29: 94–100.
20.
KillingleyBMannAJKalinovaMBoyersAGoonawardaneNZhouJ, et al.
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat Med2022;
28: 1031–1041.
21.
Garcia-FinanaMHughesDMCheyneCPBurnsideGStockbridgeMFowlerTA, et al.
Performance of the innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ2021;
374: n1637.
22.
ZhangXBarrBGreenMHughesDAshtonMCharalampopoulosD, et al.
Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study. BMJ2022;
379: e071374.
FowlerTChapmanDFutschikMETunkelSABlandfordETurekE, et al.
Self-swabbing versus assisted swabbing for viral detection by qRT-PCR: the experience from SARS-CoV-2 based on a meta-analysis of six prospectively designed evaluations conducted in a UK setting. Eur J Clin Microbiol Infect Dis2024;
43: 1621–1630.
25.
EmbrettMSimSMCaldwellHATBoulosLYuZAgarwalG, et al.
Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review. BMC Public Health2022;
22: 750.
26.
Centers for Disease Control and Prevention. Similarities and differences between flu and COVID-19. See www.cdc.gov/flu/symptoms/flu-vs-covid19.htm (last accessed 24 March 2024).
27.
PetersenEKoopmansMGoUHamerDHPetrosilloNCastelliF, et al.
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis2020;
20: e238–e244.
MuttambaWO’HareBASaxenaVBbuyeMTyagiPRamsayA, et al.
A systematic review of strategies adopted to scale up COVID-19 testing in low-, middle- and high-income countries. BMJ Open2022;
12: e060838.
33.
Bajaj S, Chen S, Creswell R, Naidoo R, Tsui JLH, Kolade O et al. COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys. The Lancet Digital Health 2024; 6: e778–e790.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
